OctreoPharm Sciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $55.8M

OctreoPharm Sciences General Information

Description

Developer of radioactively labeled pharmaceuticals. The company is focused on the development of new radiopharmaceuticals for the detection, monitoring and treatment of neuroendocrine tumors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Biomedical Research Campus Berlin-Buch
  • Robert-Roessle-Strasse 10, Building B55
  • 13125 Berlin
  • Germany
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Biomedical Research Campus Berlin-Buch
  • Robert-Roessle-Strasse 10, Building B55
  • 13125 Berlin
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OctreoPharm Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 30-Jun-2015 $55.8M Completed Generating Revenue
2. Early Stage VC 22-Jul-2013 Completed Startup
1. Early Stage VC 12-Apr-2011 $7.09M $7.09M Completed Startup
To view OctreoPharm Sciences’s complete valuation and funding history, request access »

OctreoPharm Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of radioactively labeled pharmaceuticals. The company is focused on the development of new radiopharmaceutical
Biotechnology
Berlin, Germany
11 As of 2014

Montclair, NJ
 

Columbus, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OctreoPharm Sciences Competitors (3)

One of OctreoPharm Sciences’s 3 competitors is FluoroPharma, a Formerly VC-backed company based in Montclair, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FluoroPharma Formerly VC-backed Montclair, NJ
Navidea Biopharmaceuticals Corporate Backed or Acquired Columbus, OH
Clarity Pharmaceuticals Formerly VC-backed Eveleigh, Australia
You’re viewing 3 of 3 competitors. Get the full list »

OctreoPharm Sciences Patents

OctreoPharm Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11969484-B2 Composition containing a somatostatin analogue for radiopharmaceutical use Active 21-Jun-2018
US-20230181771-A1 Composition containing a somatostatin analogue for radiopharmaceutical use Active 21-Jun-2018
EP-3015462-A1 Enantiopure chelating agents for chelator coupled pharmaceuticals, corresponding preparation method thereof and chelator coupled pharmaceuticals Inactive 29-Oct-2014 C07D255/02

OctreoPharm Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OctreoPharm Sciences Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eckert & Ziegler Holding Company Minority
Eckert Life Science Accelerator Accelerator/Incubator Minority
Eckert Wagniskapital und Frühphasenfinanzierung Venture Capital Minority
IBB Ventures Venture Capital Minority
KfW IPEX-Bank Investment Bank Minority
To view OctreoPharm Sciences’s complete investors history, request access »

OctreoPharm Sciences FAQs

  • When was OctreoPharm Sciences founded?

    OctreoPharm Sciences was founded in 2009.

  • Where is OctreoPharm Sciences headquartered?

    OctreoPharm Sciences is headquartered in Berlin, Germany.

  • What is the size of OctreoPharm Sciences?

    OctreoPharm Sciences has 11 total employees.

  • What industry is OctreoPharm Sciences in?

    OctreoPharm Sciences’s primary industry is Biotechnology.

  • Is OctreoPharm Sciences a private or public company?

    OctreoPharm Sciences is a Private company.

  • What is the current valuation of OctreoPharm Sciences?

    The current valuation of OctreoPharm Sciences is .

  • What is OctreoPharm Sciences’s current revenue?

    The current revenue for OctreoPharm Sciences is .

  • How much funding has OctreoPharm Sciences raised over time?

    OctreoPharm Sciences has raised $7.09M.

  • Who are OctreoPharm Sciences’s investors?

    Eckert & Ziegler, Eckert Life Science Accelerator, Eckert Wagniskapital und Frühphasenfinanzierung, IBB Ventures, and KfW IPEX-Bank have invested in OctreoPharm Sciences.

  • Who are OctreoPharm Sciences’s competitors?

    FluoroPharma, Navidea Biopharmaceuticals, and Clarity Pharmaceuticals are competitors of OctreoPharm Sciences.

  • When was OctreoPharm Sciences acquired?

    OctreoPharm Sciences was acquired on 30-Jun-2015.

  • Who acquired OctreoPharm Sciences?

    OctreoPharm Sciences was acquired by Ipsen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process